Compare Mutual Funds
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹1000
-
Expense Ratio
2.47
-
NAV
₹11.25
-
Fund Started
19 Nov 2024
-
Fund Size
₹95.49 Cr
-
Exit Load
Exit load of 0.50%, if redeemed within 90 days.
-
1 Year
11.50%
-
3 Year
-
-
5 Year
-
-
Equity
97.89%
-
Cash
0.20%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 11.34% |
Divi's Laboratories Ltd. | 10.01% |
JB Chemicals & Pharmaceuticals Ltd. | 6.53% |
Aster DM Healthcare Ltd. | 6.44% |
Rubicon Research Ltd. | 5.97% |
Mankind Pharma Ltd. | 5.24% |
Max Healthcare Institute Ltd. | 4.97% |
Ajanta Pharma Ltd. | 4.68% |
Krishna Institute of Medical Sciences Ltd | 4.15% |
Dr. Lal Pathlabs Ltd. | 3.27% |
-
Name
-
-
Start Date
-
-
Description
The scheme seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
-
Launch Date
19 Nov 2024
-
